Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis

The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis EVIDENCE-BASED DERMATOLOGY: STUDY SECTION EDITOR: MICHAEL BIGBY, MD; ASSISTANT SECTION EDITORS: OLIVIER CHOSIDOW, MD, PhD; ROBERT P. DELLAVALLE, MD, PhD, MSPH; DAIHUNG DO, MD; URBÀ GONZALEZ, MD, PhD; CATALIN M. POPESCU, MD, PhD; HYWEL WILLIAMS, MSc, PhD, FRCP The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis A Population-Based Cohort Study Shanu Kohli Kurd, MD, MSCE, MHS; Andrea B. Troxel, ScD; Paul Crits-Christoph, PhD; Joel M. Gelfand, MD, MSCE Objective: To determine the incidence of depression, tients with psoriasis compared with controls were 1.39 anxiety, and suicidality in patients with psoriasis com- (95% confidence interval [CI], 1.37-1.41), 1.31 (95% CI, pared with the general population. 1.29-1.34), and 1.44 (95% CI, 1.32-1.57), respectively. The adjusted HR of depression was higher in severe (HR, Design: A population-based cohort study using data col- 1.72; 95% CI, 1.57-1.88) compared with mild psoriasis lected as part of patient’s electronic medical record from (HR, 1.38; 95% CI, 1.35-1.40). Younger patients with pso- 1987 to 2002. riasis had elevated HRs of outcomes compared with older patients with psoriasis. Setting: General Practice Research Database. Conclusions: Patients with psoriasis have an increased Patients: Analyses included 146 042 patients with mild risk of depression, anxiety, and suicidality. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis

Loading next page...
 
/lp/american-medical-association/the-risk-of-depression-anxiety-and-suicidality-in-patients-with-mM6qF0jJV9

References (27)

Publisher
American Medical Association
Copyright
Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2010.186
pmid
20713823
Publisher site
See Article on Publisher Site

Abstract

EVIDENCE-BASED DERMATOLOGY: STUDY SECTION EDITOR: MICHAEL BIGBY, MD; ASSISTANT SECTION EDITORS: OLIVIER CHOSIDOW, MD, PhD; ROBERT P. DELLAVALLE, MD, PhD, MSPH; DAIHUNG DO, MD; URBÀ GONZALEZ, MD, PhD; CATALIN M. POPESCU, MD, PhD; HYWEL WILLIAMS, MSc, PhD, FRCP The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis A Population-Based Cohort Study Shanu Kohli Kurd, MD, MSCE, MHS; Andrea B. Troxel, ScD; Paul Crits-Christoph, PhD; Joel M. Gelfand, MD, MSCE Objective: To determine the incidence of depression, tients with psoriasis compared with controls were 1.39 anxiety, and suicidality in patients with psoriasis com- (95% confidence interval [CI], 1.37-1.41), 1.31 (95% CI, pared with the general population. 1.29-1.34), and 1.44 (95% CI, 1.32-1.57), respectively. The adjusted HR of depression was higher in severe (HR, Design: A population-based cohort study using data col- 1.72; 95% CI, 1.57-1.88) compared with mild psoriasis lected as part of patient’s electronic medical record from (HR, 1.38; 95% CI, 1.35-1.40). Younger patients with pso- 1987 to 2002. riasis had elevated HRs of outcomes compared with older patients with psoriasis. Setting: General Practice Research Database. Conclusions: Patients with psoriasis have an increased Patients: Analyses included 146 042 patients with mild risk of depression, anxiety, and suicidality.

Journal

JAMA DermatologyAmerican Medical Association

Published: Aug 1, 2010

There are no references for this article.